LS60 Stock Overview
Engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
My Notes
Capture your thoughts, links and company narrative
Clinical Laserthermia Systems AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.30 |
| 52 Week High | SEK 2.46 |
| 52 Week Low | SEK 0.04 |
| Beta | 0.30 |
| 1 Month Change | 17.19% |
| 3 Month Change | -35.34% |
| 1 Year Change | -62.50% |
| 3 Year Change | -99.60% |
| 5 Year Change | -99.79% |
| Change since IPO | -99.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| LS60 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 2.0% | 2.9% | 1.9% |
| 1Y | -62.5% | -1.0% | 15.1% |
Return vs Industry: LS60 underperformed the German Medical Equipment industry which returned -1% over the past year.
Return vs Market: LS60 underperformed the German Market which returned 15.1% over the past year.
Price Volatility
| LS60 volatility | |
|---|---|
| LS60 Average Weekly Movement | 21.1% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: LS60's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: LS60's weekly volatility has decreased from 185% to 21% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 17 | Dan Mogren | www.clinicallaser.se |
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment.
Clinical Laserthermia Systems AB (publ) Fundamentals Summary
| LS60 fundamental statistics | |
|---|---|
| Market cap | €6.98m |
| Earnings (TTM) | -€5.59m |
| Revenue (TTM) | €1.62m |
4.3x
P/S Ratio-1.3x
P/E RatioIs LS60 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LS60 income statement (TTM) | |
|---|---|
| Revenue | SEK 18.63m |
| Cost of Revenue | SEK 11.53m |
| Gross Profit | SEK 7.10m |
| Other Expenses | SEK 71.30m |
| Earnings | -SEK 64.20m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 21, 2025
| Earnings per share (EPS) | -3.18 |
| Gross Margin | 38.09% |
| Net Profit Margin | -344.68% |
| Debt/Equity Ratio | 2.0% |
How did LS60 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/02 19:10 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Clinical Laserthermia Systems AB (publ) is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hans Mähler | Nordea Markets |
| Erik Nordström | Redeye |
| Gustaf Meyer | Redeye |